Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

DESLORATADINE; PSEUDOEPHEDRINE SULFATE 24 HOUR

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

54 API Suppliers, 14 USDMF, 13 CEP/COS, 3 JDMF, 20 EU WC, 4 KDMF, 7 NDC API, 34 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

23 Drugs in Development

23 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

350 FDF Dossiers, 24 FDA Orange Book, 203 Europe, 6 Canada, 56 South Africa, 61 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG, SOLUTION;ORAL - 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 2.5MG;120MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 Evonik, 3 Rochem International Inc, 23 SPI Pharma, 6 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 6 Kirsch Pharma, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 28 BASF, 1 CD Formulation, 12 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 39 Direct Compression, 35 Granulation, 34 Disintegrants & Superdisintegrants, 32 Taste Masking, 32 Thickeners and Stabilizers, 29 Controlled & Modified Release, 25 Lubricants & Glidants, 24 Solubilizers, 23 Film Formers & Plasticizers, 22 Chewable & Orodispersible Aids, 21 Parenteral, 17 Topical, 13 Co-Processed Excipients, 9 Emulsifying Agents, 7 API Stability Enhancers, 7 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 6 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 63 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

28 APIs, 10 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 5 USP, 24 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
25/11/2025	Shandong Loncom Pharmaceutical	China	Shandong Loncom Pharmaceutical Co. Ltd.	SD230056	Desloratadine	2023-06-28	2026-09-12	127, Qizhong Avenue, Yanbei Sub-district, China-251, Qihe, Shandong
04/06/2025	Tagoor Laboratories	India	M/s Tagoor Laboratories Pvt ltd	WC-0494	Desloratadine Ph.Eur/BP/USP	2024-08-16	2027-02-26	(Unit-1), Sy No 29, Tupakulagudem (V), Pochavaram Panchayat, Tallapudi (M), West Godavari, Dist-534341, A.P, India

DESLORATADINE; PSEUDOEPHEDRINE SULFATE 24 HOUR

DESLORATADINE; PSEUDOEPHEDRINE SULFATE 24 HOUR

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

54 API Suppliers

14 USDMF

13 CEP/COS

3 JDMF

20 EU WC

4 KDMF

7 NDC API

34 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

23 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

350 FDF Dossiers

24 FDA Orange Book

203 Europe

6 Canada

56 South Africa

61 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG

SOLUTION;ORAL - 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 2.5MG;120MG

RELATED EXCIPIENT COMPANIES

1 Minakem

5 Evonik

3 Rochem International Inc

23 SPI Pharma

6 DKSH

1 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

6 Kirsch Pharma

1 ACG Worldwide

9 Actylis

1 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

28 BASF

1 CD Formulation

12 Corel Pharma Chem

7 DFE Pharma

1 Doshion Polyscience

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

5 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

4 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

29 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

2 The Dow Chemical Company

2 Valens Pharmachem

SOLUTION;ORAL - 0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons